Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma

Autor: Brian L. Gallagher, Fadi N. Joudi, Melissa M. Meier, Henry M. Rosevear

Publikováno v: The Scientific World Journal, Vol 9, Pp 5-9 (2009)
The Scientific World Journal

Xanthogranulomatous pyelonephritis (XGP) is a chronic inflammatory process that results in replacement of renal and/or perirenal tissue with a diffuse infiltrate of inflammatory cells referred to as xanthoma cells. We present a case of a 49-year-old

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42117c6da33dd8ba349d9f3d0a459e95
https://doaj.org/article/3366c8af22824f3e8f2ccadef4b3f12a

Abstract 439: Glycosylation of α-dystroglycan in prostate cancer: Prognostic implications and regulation by LARGE2

Autor: Brian J. Smith, Michael B. Cohen, Michael R. Miller, Robert L. Vessella, Michael D. Henry, Melissa M. Meier, Charles F. Lynch, Christine J. Weydert, Alison K. Esser

Publikováno v: Cancer Research. 72:439-439

Cancer cells exhibit altered interactions with their extracellular matrix microenvironment that are thought to underlie tumor progression and metastasis. Dystroglycan (DG) is a receptor for extracellular matrix proteins including laminins and perleca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ca066927932a5b9c1bc743d145a632b
https://doi.org/10.1158/1538-7445.am2012-439

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma.

Autor: Sanlorenzo M; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Electronic address: martina.sanlorenzo@hotmail.it., Choudhry A; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Vujic I; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria., Posch C; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria., Chong K; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Johnston K; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Meier M; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Osella-Abate S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy., Daud A; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Algazi A; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California., Rappersberger K; Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria., Ortiz-Urda S; University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2014 Dec; Vol. 71 (6), pp. 1102-1109.e1. Date of Electronic Publication: 2014 Oct 16.